SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019823
Filing Date
2024-05-15
Accepted
2024-05-15 16:05:59
Documents
65
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 700428
2 ex31-1.htm EX-31.1 17525
3 ex31-2.htm EX-31.2 17534
4 ex32-1.htm EX-32.1 7708
  Complete submission text file 0001493152-24-019823.txt   3932176

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ntbl-20240331.xsd EX-101.SCH 35510
6 XBRL CALCULATION FILE ntbl-20240331_cal.xml EX-101.CAL 50368
7 XBRL DEFINITION FILE ntbl-20240331_def.xml EX-101.DEF 97148
8 XBRL LABEL FILE ntbl-20240331_lab.xml EX-101.LAB 287302
9 XBRL PRESENTATION FILE ntbl-20240331_pre.xml EX-101.PRE 220612
69 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 478618
Mailing Address 320 HATCH DRIVE FOSTER CITY CA 94404
Business Address 320 HATCH DRIVE FOSTER CITY CA 94404 415-851-2410
Notable Labs, Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36581 | Film No.: 24950430
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)